1. Screening Libraries
  2. Kinase Inhibitor Library

Kinase Inhibitor Library

Cat. No.: HY-L009
Library Contents: XLSX PDF

A unique collection of 757 phosphorylation kinase inhibitors/regulators for high throughput screening (HTS) and high content screening (HCS).

Size (Pre-dissolved DMSO or Solid) Price Stock
30 μL/well (10 mM solution) Get quote In-stock
50 μL/well (10 mM solution) Get quote In-stock
100 μL/well (10 mM solution) Get quote In-stock
250 μL/well (10 mM solution) Get quote In-stock

Please contact us at

[email protected]

Top Publications Citing Use of Products

MCE Screening Library Partners

  • Description

  • Product Details

  • Composition

  • Contents

  • Documentation

Description
& Advantages

•   A unique collection of 757 phosphorylation kinase inhibitors/regulators for high throughput screening (HTS) and high content screening (HCS).

•   The library contains compounds targeting protein kinases (VEGFR, EGFR, BTK, CDK, Akt, etc.), lipid kinases (PI3K, PI4K, SK, etc.) and carbohydrate kinases (Hexokinase).

•   Kinase inhibitors have played an increasingly prominent role in the treatment of cancer and other diseases.

•   Bioactivity and safety confirmed by preclinical research and clinical trials. Some inhibitors have been approved by FDA.

•   Structurally diverse, medicinally active, and cell permeable.

•   Rich documentation with structure, IC50, and customer reviews.

•   NMR and HPLC validated to ensure high purity.

•   All compounds are in stock and continuously updated.

Product Details
Formulation:
A collection of 757 kinase inhibitors/regulators supplied as pre-dissolved DMSO solutions or Solid
Container:
96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode
Storage:
-80°C
Shipping:
Blue ice
Composition

Kinase Inhibitor Library

Source: MedChem Express

Contents of Kinase Inhibitor Library

Plate layout: HY-L009-1

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Jujuboside A 3-Methyladenine 5-Aminosalicylic acid 2-Deoxy-D-glucose Metformin (hydrochloride) 3-Bromopyruvic acid Poloxime AG 18 Scopoletin MNS Empty
b Empty 4μ8C Trapidil CID755673 SP600125 RIPA-56 TDZD-8 SC-514 Resveratrol NSC95682 SU5416 Empty
c Empty Danthron SU9516 Phenformin (hydrochloride) CGP 57380 Piceatannol IQ-1S (free acid) NU2058 Y-27632 TG003 PHA-767491 (hydrochloride) Empty
d Empty kb NB 142-70 TPI-1 Chrysophanol BMS-345541 (free base) Bakuchiol AS-605240 AICAR Necrostatin-1 SMI-16a Anisomycin Empty
e Empty RG13022 Honokiol PD98059 Formononetin Apigenin Genistein Emodin SAR245409 Butein LY-364947 Empty
f Empty Bikinin TCS-PIM-1-4a RG14620 GW 441756 TC-DAPK 6 SC66 Indirubin-3'-monoxime TPCA-1 NU 7026 Compound 401 Empty
g Empty PP1 BX517 Tyrphostin A9 Y15 Wogonin Dihydroartemisinin Scutellarein A 77-01 RepSox Zoledronic acid (monohydrate) Empty
h Empty BMS-345541 CHR-6494 IRAK inhibitor 1 AG-490 [6]-Gingerol SU 5402 PF-06260933 JANEX-1 Poloxin SKF-86002 Empty

Plate layout: HY-L009-2

1 2 3 4 5 6 7 8 9 10 11 12
a Empty ID-8 Amlexanox Salidroside Nocodazole PP2 Quercetin SKI II MCB-613 AG1024 AS-252424 Empty
b Empty NSC23005 (sodium) PF-06447475 IRAK inhibitor 2 Ruxolitinib LY294002 Hydroxyfasudil Fingolimod AR-A014418 PP 242 LY3177833 Empty
c Empty INK-128 TSU-68 IC261 Thiazovivin AT13148 STO-609 AG-1478 Isorhamnetin Tyrphostin AG 879 LH846 Empty
d Empty STF-083010 1-Naphthyl PP1 TWS119 PP121 Vps34-PIK-III Dihydromyricetin Y-27632 (dihydrochloride) Triciribine SKLB1002 Lonidamine Empty
e Empty AG 555 PS-1145 Bupivacaine (hydrochloride) XL413 (hydrochloride) RKI-1447 Peficitinib Kenpaullone FR 180204 Fasudil (Hydrochloride) PD158780 Empty
f Empty TTP 22 SB 202190 1-NM-PP1 APY29 KW-2449 TCS JNK 5a Oglufanide GSK1059615 ZM 306416 GDC-0879 Empty
g Empty Tideglusib SL327 ML167 SB-505124 Dicoumarol DPH CC-115 AT7867 LM22A-4 Pim1/AKK1-IN-1 Empty
h Empty NVP-BVU972 PRT-060318 MSC2530818 PQ401 CCT128930 SB 525334 Fingolimod (hydrochloride) ETC-1002 BMS-265246 SSR128129E Empty

Plate layout: HY-L009-3

1 2 3 4 5 6 7 8 9 10 11 12
a Empty TG100-115 NG 52 L-779450 PI-103 Ingenol AZD-1480 CP-466722 SRPIN340 CX-4945 IPA-3 Empty
b Empty TA-01 Ro-3306 K02288 ML347 SD-208 1-Naphthyl PP1 (hydrochloride) VS-5584 Roscovitine TPX-0005 ISCK03 Empty
c Empty Coptisine (chloride) CGP60474 BIO WP1066 AICAR (phosphate) CH5183284 R1530 TAS-301 SAR131675 SGX-523 Empty
d Empty SB 415286 LFM-A13 PD153035 PD 169316 A-769662 TCS 359 PF06650833 PHA-793887 ZLN024 (hydrochloride) AZD-7762 Empty
e Empty MLN1117 R-268712 BML-277 CDK-IN-2 EMD638683 CZC24832 TGX-221 SC79 GSK180736A GW2580 Empty
f Empty MLN120B TCS PIM-1 1 APTO-253 Sanguinarine (chloride) ZM39923 (hydrochloride) LJI308 SB 239063 VE-821 PD168393 Tivantinib Empty
g Empty LY2157299 Brivanib MSDC 0160 LDC000067 SB 216763 Baricitinib AIM-100 SU6656 AZD-5438 CX-4945 (sodium salt) Empty
h Empty PF-04217903 Tetrahydrocurcumin SB1317 TEPP-46 CC-115 (hydrochloride) Src Inhibitor 1 Motesanib GNF-2 CRT0066101 dihydrochloride Linifanib Empty

Plate layout: HY-L009-4

1 2 3 4 5 6 7 8 9 10 11 12
a Empty ENMD-2076 WHI-P154 JNJ-38877605 IM-12 CH5132799 SB 203580 HG-10-102-01 Ro 28-1675 CCT245737 BI-78D3 Empty
b Empty MLi-2 AZD1208 PF-4989216 DMH-1 ZINC00881524 SNS-032 TAK-659 (hydrochloride) CL-387785 LJH685 AT9283 Empty
c Empty PLX647 GDC-0326 GSK 650394 EAI045 Losmapimod GSK'872 IMD-0354 Chelerythrine Chloride WP1130 SB-431542 Empty
d Empty PI-103 (Hydrochloride) SNS-062 K145 (hydrochloride) AMG319 Acumapimod TIC10 TIC10 isomer MHY1485 APS-2-79 BIBX 1382 Empty
e Empty CPDA Purvalanol A T56-LIMKi ZM 336372 Solcitinib PIK-93 PF-4708671 BI-D1870 5-Iodotubercidin Latrepirdine (dihydrochloride) Empty
f Empty Dovitinib Fruquintinib Erlotinib Reversine A66 IRAK-1-4 Inhibitor I KU-55933 Tanshinone IIA sulfonate (sodium) PD-166866 Toceranib Empty
g Empty IRAK inhibitor 6 Dinaciclib CID 2011756 IC-87114 CC-223 D4476 GSK583 Sunitinib BLZ945 GSK2578215A Empty
h Empty EW-7197 HLM006474 TAK-715 CVT-313 ACHP (Hydrochloride) Acalisib Flavopiridol Dehydrocorydaline (chloride) VX-702 Ruxolitinib (phosphate) Empty

Plate layout: HY-L009-5

1 2 3 4 5 6 7 8 9 10 11 12
a Empty SGI-1776 PF-06463922 Palomid 529 OSI-027 LY3023414 LDN-212854 ANA-12 SR-3677 AZD 6482 PHT-427 Empty
b Empty Telatinib PF-670462 NVP-BKM120 AT7867 (dihydrochloride) PQR309 GS-9973 ZM323881 (hydrochloride) NT157 INCB28060 BIX02188 Empty
c Empty AZ20 AZD6738 APY0201 KU-57788 PLX-4720 SB 203580 (hydrochloride) AXL1717 CYT387 LTURM34 GNE-317 Empty
d Empty GSK2256098 SKLB610 CAL-101 ITD-1 Tomatidine GSK2656157 KRN-633 JH-II-127 Duvelisib Duvelisib (R enantiomer) Empty
e Empty ZSTK474 CP-673451 Pexidartinib GNF-5 TP-3654 AT7519 (Hydrochloride) LDN-214117 Vatalanib (dihydrochloride) CHIR-124 Linsitinib Empty
f Empty URMC-099 HS-173 CHZ868 AVL-292 AM-2394 NVP-BAW2881 HMN-214 LY3009120 CC-401 (hydrochloride) PF-04691502 Empty
g Empty GW788388 GSK-690693 GLPG0634 Vps34-IN-1 U0126 Lenvatinib Afuresertib Icotinib (Hydrochloride) LOXO-101 AZD5363 Empty
h Empty GSK2141795 BMS-3 ON123300 AZ191 Erlotinib (Hydrochloride) PRT062607 (Hydrochloride) AS703026 BMS-5 MK-8745 GSK429286A Empty

Plate layout: HY-L009-6

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Torin 2 LDC4297 BMS-911543 Purvalanol B VRT752271 GSK2636771 CUDC-101 LEE011 TBB VX-745 Empty
b Empty LY2603618 Pazopanib XL228 Flavopiridol (Hydrochloride) Sotrastaurin S49076 PCI-32765 BIX02189 UNC2250 AEE788 Empty
c Empty MEK162 Brivanib (alaninate) BYL-719 LY2109761 SU14813 Go 6983 AZM475271 GNE-7915 OSI-930 Crenolanib Empty
d Empty LY2874455 SAR-20347 Cerdulatinib PF-04979064 Erdafitinib NVP-BKM120 (Hydrochloride) Gefitinib AZD2932 Amuvatinib Quercitrin Empty
e Empty PI3K inhibitor X AZD-3463 Crizotinib Cediranib ISRIB (trans-isomer) GSK2606414 AZ 628 SUN11602 SLx-2119 GDC-0349 Empty
f Empty AZ3146 Oclacitinib (maleate) AZD2858 SB-590885 ONO-4059 Tivozanib WHI-P97 SGI-7079 GDC-0623 BRAF inhibitor Empty
g Empty ONO-4059 (analog) AZD8186 AS 602801 Selumetinib GDC-0068 AZD3759 NVP-LCQ195 GDC-0032 PHA-848125 AZD8330 Empty
h Empty Necrosulfonamide BMS-754807 AZD0156 Perifosine MK-5108 CX-6258 Scutellarin AZD2014 CEP-33779 GSK2334470 Empty

Plate layout: HY-L009-7

1 2 3 4 5 6 7 8 9 10 11 12
a Empty BAY 61-3606 (dihydrochloride) AMG-337 VE-822 AZD4547 UNC2881 Afuresertib (hydrochloride) BI-847325 Tozasertib MRT67307 Sorafenib Empty
b Empty CHIR-99021 Acalabrutinib KU-0063794 AZD-8055 JI-101 YM-201636 Pelitinib Mubritinib PF-04217903 (methanesulfonate) HTH-01-015 Empty
c Empty BMS-794833 NVP-TAE 226 Baricitinib (phosphate) Ki8751 CP-724714 AZD-8835 Dacomitinib LY2784544 R406 (free base) ETP-46464 Empty
d Empty MRT68921 (hydrochloride) BX-912 Ro 5126766 Dorsomorphin (dihydrochloride) Rigosertib (sodium) Sapitinib Pazopanib (Hydrochloride) PF-03814735 XMD8-92 Danusertib Empty
e Empty Vandetanib UNC2025 DMAT MLN8054 GW843682X CI-1040 AZD7545 B-Raf inhibitor 1 CCT241533 (hydrochloride) SBE13 (Hydrochloride) Empty
f Empty NVS-PAK1-1 BMS-536924 MK 2206 (dihydrochloride) Irbinitinib Mps1-IN-2 PD0325901 Dovitinib (lactate) CH5424802 Regorafenib IKK 16 Empty
g Empty Palbociclib (hydrochloride) Uridine triphosphate LY2409881 AZ-5104 Afatinib CHIR-98014 Olmutinib Crizotinib (hydrochloride) Dasatinib Bucladesine (calcium salt) Empty
h Empty CZC-25146 PIK-75 DCC-2618 PIK-294 Vemurafenib PF-3758309 ONO-4059 (hydrochloride) Poziotinib Bucladesine (sodium salt) PF-573228 Empty

Plate layout: HY-L009-8

1 2 3 4 5 6 7 8 9 10 11 12
a Empty EMD-1214063 Apatinib Imatinib Toceranib (phosphate) WZ4002 WYE-354 AT7519 (trifluoroacetate) WZ4003 CCT129202 GDC-0980 Empty
b Empty Masitinib CNX-774 CDK9-IN-1 AZD-9291 VX-11e MK-1775 Regorafenib (monohydrate) PND-1186 Cabozantinib PHA-680632 Empty
c Empty NVP-BHG712 AMG 900 TAK-733 Tofacitinib (citrate) TAK-901 CZC-54252 GSK2126458 MLN 2480 PI-3065 PF-562271 Empty
d Empty AZD1152-HQPA JNK-IN-8 GSK-1070916 BLU9931 TG101209 Defactinib LY2090314 BMS 777607 SCIO-469 UNC2025 (hydrochloride) Empty
e Empty FRAX486 CCT196969 ZM-447439 GDC-0941 Enzastaurin TP-0903 PDK1 inhibitor Hesperadin CEP-32496 MGCD-265 analog Empty
f Empty ALK inhibitor 2 RAF265 Alisertib CH5424802 (Hydrochloride) Regorafenib (Hydrochloride) H-89 (dihydrochloride) Dabrafenib WYE-125132 GW 5074 BI 2536 Empty
g Empty Tauroursodeoxycholate (Sodium) PD173074 Dasatinib (hydrochloride) TG-101348 LOXO-101 (sulfate) SNS-314 KX2-391 (Mesylate) Doramapimod IPI549 ALK-IN-1 Empty
h Empty Nilotinib AST 487 Lck Inhibitor GDC-0068 (dihydrochloride) Cobimetinib NMS-1286937 GZD824 Ponatinib GSK1838705A CFI-400945 (free base) Empty

Plate layout: HY-L009-9

1 2 3 4 5 6 7 8 9 10 11 12
a Empty GNF-5837 Mps1-IN-1 BIBF 1120 XL-147 Saracatinib PLX8394 GSK461364 CNX-2006 Defactinib (hydrochloride) GNF-7 Empty
b Empty KU-60019 TAK-285 Pluripotin CCT 137690 AKT inhibitor VIII LDN193189 (Hydrochloride) LY2801653 DDR1-IN-1 LEE011 (succinate) DCC-2036 Empty
c Empty Ro 31-8220 (mesylate) TAK-632 CO-1686 CGK733 Neratinib LDK378 SU14813 (maleate) Canertinib (dihydrochloride) NVP-BGJ398 LDC1267 Empty
d Empty Entrectinib Quizartinib PD318088 BAY1217389 TAK-960 Flumatinib Tandutinib NVP-BSK805 (dihydrochloride) THZ1 Cediranib (maleate) Empty
e Empty BMS-599626 (Hydrochloride) SU11274 WH-4-023 Motesanib (Diphosphate) GSK269962A LEE011 (succinate hydrate) LRRK2-IN-1 TGR-1202 Refametinib Palbociclib (isethionate) Empty
f Empty CHIR-99021 (trihydrochloride) Bafetinib Belizatinib CGI-1746 CEP-37440 ASP3026 Lapatinib Nilotinib (monohydrochloride monohydrate) Brigatinib Aurora A inhibitor I Empty
g Empty Imatinib (Mesylate) BX795 A 419259 (trihydrochloride) Masitinib (mesylate) AZD-9291 (mesylate) PI3K-IN-1 THZ1 (Hydrochloride) LY2835219 Avitinib (maleate) Torin 1 Empty
h Empty KRCA-0008 CYT387 (sulfate salt) EG00229 Neohesperidin dihydrochalcone LY2228820 NVP-TAE 684 Trametinib GNE-7915 (tosylate) Dabrafenib (Mesylate) LY-2584702 (tosylate salt) Empty

Plate layout: HY-L009-10

1 2 3 4 5 6 7 8 9 10 11 12
a Empty Volasertib LYN-1604 hydrochloride Ginsenoside Rh2 R788(prodrug of R406) Verbascoside R406 Sitravatinib LDK378 (dihydrochloride) Centrinone-B Foretinib Empty
b Empty Centrinone TAK-960 (dihydrochloride) FIIN-2 CEP-28122 (mesylate salt) Cabozantinib (S-malate) CO-1686 (hydrobromide) Sorafenib (Tosylate) XMD17-109 PHA-665752 BEZ235 (Tosylate) Empty
c Empty Cobimetinib (hemifumarate) BIBF 1120 (esylate) NVP-BGT226 CFI-400945 (fumarate) Flumatinib (mesylate) GDC-0853 PF-562271 (besylate) Icariin Trametinib (DMSO solvate) SCR-1481B1 Empty
d Empty GDC-0941 (dimethanesulfonate) Afatinib (dimaleate) KN-62 R788 (disodium hexahydrate) Astragaloside IV GSK1904529A Lapatinib (ditosylate) Empty Empty Empty Empty
e Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
f Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
g Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
h Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty Empty
View More Collapse
Documentation

Inquiry Online

Your information is safe with us. * Required Fields.

Product name

 

Salutation

Applicant name *

 

Email address *

Phone number

 

Organization name *

Country *

 

Requested quantity *

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Kinase Inhibitor Library
Cat. No.:
HY-L009
Quantity:

Request SDF File

Please enter your email address. We will send your requested SDF file to you as soon as possible.